Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.

NCT03869762 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

NETWORK

Sponsor class

Stopped Insufficient accrual

Conditions

Castration-resistant Prostate Cancer
Metastatic Cancer
Bone Metastases

Interventions

DRUG: Xgeva
DRUG: Xtandi

Sponsor

Cancer Trials Ireland